A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

NCT07477704 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Alirocumab

Sponsor

Regeneron Pharmaceuticals